scholarly article | Q13442814 |
P50 | author | Steven J Jacobsen | Q37384936 |
Karla V Ballman | Q48925439 | ||
Cynthia S Crowson | Q87215892 | ||
Hilal Maradit Kremers | Q88386643 | ||
Paulo Nicola | Q88783656 | ||
W. Michael O'Fallon | Q102207830 | ||
Véronique L. Roger | Q110955107 | ||
P2093 | author name string | Terry M Therneau | |
Sherine E Gabriel | |||
P2860 | cites work | Mechanisms and models in heart failure: A combinatorial approach | Q33723469 |
Chronic heart failure in the United States: a manifestation of coronary artery disease | Q41700419 | ||
P433 | issue | 10 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
heart failure | Q181754 | ||
circulatory system | Q11068 | ||
P304 | page(s) | 3039-3044 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? | |
P478 | volume | 52 |
Q35501450 | A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis |
Q52587395 | Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity. |
Q87035377 | Arterial stiffness is associated with left ventricular dysfunction in patients with rheumatoid arthritis |
Q90623245 | Associations of inflammatory markers with impaired left ventricular diastolic and systolic function in collagen-induced arthritis |
Q85069915 | Biologics and cardiovascular risk |
Q33898103 | Biologics and heart failure in rheumatoid arthritis: are we any wiser? |
Q87997758 | Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives |
Q36355415 | Cardiac manifestations of rheumatological conditions: a narrative review |
Q33582869 | Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions. |
Q89612695 | Cardiovascular MRI evidence of reduced systolic function and reduced LV mass in rheumatoid arthritis: impact of disease phenotype |
Q26823443 | Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure |
Q33806651 | Cardiovascular morbidity and mortality in rheumatoid arthritis |
Q82835412 | Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model |
Q37142052 | Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs |
Q36789902 | Differing trends in the incidence of vascular comorbidity in MS and the general population |
Q34986307 | Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. |
Q40233931 | Five-year changes in cardiac structure and function in patients with rheumatoid arthritis compared with the general population |
Q35019085 | Heart disease and rheumatoid arthritis: understanding the risks |
Q36742762 | Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists |
Q34090034 | High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study |
Q37141004 | Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: key diagnostic features and literature review. |
Q34724972 | Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care |
Q34459100 | Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease |
Q37060522 | Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction |
Q38393039 | Innate immunity and the failing heart: the cytokine hypothesis revisited |
Q45265863 | Left ventricular morphology and function in patients with rheumatoid arthritis |
Q44051899 | Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease |
Q52562359 | Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. |
Q49387418 | Prevalence of left ventricular dysfunction in rheumatoid arthritis |
Q28242377 | Proteomics of citrullination in cardiovascular disease |
Q35638288 | Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis |
Q36001551 | Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative |
Q36574986 | Rheumatoid arthritis and the heart |
Q35638369 | Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis |
Q40065441 | Sex and Cardiovascular Involvement in Inflammatory Joint Diseases |
Q41264898 | Sudden cardiac death in patients with rheumatoid arthritis |
Q48214698 | The Impact of Different Classification Criteria Sets on the Estimated Prevalence and Associated Risk Factors of Diastolic Dysfunction in Rheumatoid Arthritis |
Q37027093 | The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases |
Q44558171 | The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis |
Q36596365 | The heart and cardiovascular manifestations in rheumatoid arthritis |
Q35915244 | The influence of rheumatoid arthritis disease characteristics on heart failure. |
Q37074034 | The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. |
Q36308939 | To Tell or Not to Tell: Shared Decision Making, CAM Use and Disclosure Among Underserved Patients with Rheumatic Diseases |
Q54965764 | Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis. |
Q40555407 | Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark |
Q33697879 | Why do people with rheumatoid arthritis still die prematurely? |
Search more.